Predictive factors for acute and late urinary toxicity after permanent interstitial brachytherapy in <scp>J</scp>apanese patientsRyuta Tanimoto, Hiromi Kumon, Kensuke Bekku et al.|International Journal of Urology|2013Cited by 14
First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safetyTakafumi Yanagisawa, Takahiro Kimura, Keiichiro Mori et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 7
Oncological impact of neoadjuvant hormonal therapy on permanent iodine‐125 seed brachytherapy in patients with low‐ and intermediate‐risk prostate cancerAtsushi Takamoto, Yasutomo Nasu, Shin Ebara et al.|International Journal of Urology|2018Cited by 3
Predictive factors for acute and late urinary toxicities after permanent prostate brachytherapy.Ryuta Tanimoto, Hiromi Kumon, Kensuke Bekku et al.|Journal of Clinical Oncology|2012Cited by 1
PO-0972: Interobserver variability of 3T and 1.5T MRI/CT fusion-based postimplant dosimetry of prostate brachytherapyNorihisa Katayama, Shigenori Kanazawa, M. Yamashita et al.|Radiotherapy and Oncology|2013Cited by 0